In vitro and in silicostudies were used to evaluate silodosin,a potential triple inhibitor of AChE, BuChE, and BACE-1 previouslyidentified through hierarchical virtual screening, as a candidatefor the treatment of AD. The gene discussed is BACE1; the disease is Alzheimer disease.